Metagenomi
Presence
Acquisition, funding and merger involving Metagenomi.
- Metagenomi has just announced a $100 Million fundraising (posted on January 10 2024).
- Metagenomi has just announced a $100 Million fundraising (posted on January 11 2023).
Executives
View the org chart displaying its 17 main executives
Most searched biographies at Metagenomi
- Brian Thomas, Chief Executive Officer and Director
- Sebastian Bernales, Director
- Jürg Eckhardt, Director
Popular executive movements at Metagenomi
- Pamela Wapnick has joined the company as Chief Financial Officer (posted on November 10 2023).
- Luis Borges has joined the company as Chief Scientific Officer (posted on November 10 2023).
Create your alert
to follow the executive moves at Metagenomi.
Biotechnology
Metagenomi has 2,290 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Delphia Therapeutics has just announced a $67 Million fundraising (posted on May 7 2024).
- Karius has just announced a $100 Million fundraising (posted on May 3 2024).
- Transcarent has just announced a $126 Million fundraising (posted on May 2 2024).
Popular contacts in Biotechnology
News
Press releases by Metagenomi
- Metagenomi Announces Publication of Data in Nature Communications Describing Novel, Ultra-Small Nucleases for Gene Editing - Metagenomi
- After blazing trails in RNA-targeted drugs, Ionis jumps into gene editing
- Ionis Partners with Metagenomi to Add Gene Editing to its Broad Technology Platform - Metagenomi
- Mining (and Refining) the Stuff of Gene Editing Tools
- Metagenomi Announces Opening of Manufacturing Facility for its Next Generation CRISPR Gene-Editing Systems and Therapies - Metagenomi
- Metagenomi Announces Participation in October Investor and Industry Conferences - Metagenomi
- The Meta(nuclease)verse: Metagenomi Is Developing the Next Generation of Gene-Editing Therapies
- Metagenomi Named an Endpoints 11 Winner - Metagenomi
- Metagenomi Announces Participation in September Investor and Industry Conferences - Metagenomi
- Affini-T Therapeutics & Metagenomi Announce Next-Generation Gene Editing Partnership to Advance Cell Therapies for Solid Tumor Patients - Metagenomi
- View more press releases Close
Social media about Metagenomi
- Metagenomi on Wikipedia, Google News & Yahoo Finance
- Metagenomi on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Brian Thomas 
